Terms: = Ovarian cancer AND SOCS1, O15524, 8651, ENSG00000185338, SOCS-1, SSI-1, SSI1, Cish1, JAB, CISH1, CIS1, TIP3
17 results:
1. Cytotoxic lymphocytes-related gene ITK from a systematic CRISPR screen could predict prognosis of ovarian cancer patients with distant metastasis.
Xu M; Huang S; Chen J; Xu W; Xiang R; Piao Y; Zhao S
J Transl Med; 2021 Oct; 19(1):447. PubMed ID: 34702300
[TBL] [Abstract] [Full Text] [Related]
2. IFN-γ inhibits ovarian cancer progression via socs1/JAK/STAT signaling pathway.
Gao AH; Hu YR; Zhu WP
Clin Transl Oncol; 2022 Jan; 24(1):57-65. PubMed ID: 34275119
[TBL] [Abstract] [Full Text] [Related]
3. Intratumoral Delivery of an Adenoviral Vector Carrying the
Nakagawa S; Serada S; Kakubari R; Hiramatsu K; Sugase T; Matsuzaki S; Matsuzaki S; Ueda Y; Yoshino K; Ohkawara T; Fujimoto M; Kishimoto T; Kimura T; Naka T
Mol Cancer Ther; 2018 Sep; 17(9):1941-1950. PubMed ID: 29891489
[TBL] [Abstract] [Full Text] [Related]
4. Upregulation of miR-572 transcriptionally suppresses socs1 and p21 and contributes to human ovarian cancer progression.
Zhang X; Liu J; Zang D; Wu S; Liu A; Zhu J; Wu G; Li J; Jiang L
Oncotarget; 2015 Jun; 6(17):15180-93. PubMed ID: 25893382
[TBL] [Abstract] [Full Text] [Related]
5. Guanidine platinum(II) complexes: synthesis, in vitro antitumor activity, and DNA interactions.
Legin AA; Jakupec MA; Bokach NA; Tyan MR; Kukushkin VY; Keppler BK
J Inorg Biochem; 2014 Apr; 133():33-9. PubMed ID: 24444821
[TBL] [Abstract] [Full Text] [Related]
6. [Expression of miR-130a in cisplatin resistant cell lines of ovarian cancer].
Yang LY; Wang HJ; Jia XB; Wang X; Luo J; Zhang XY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Jan; 43(1):60-4. PubMed ID: 22455133
[TBL] [Abstract] [Full Text] [Related]
7. Urinary neopterin does not reflect the local antitumor immune milieu in ovarian cancer.
Zeimet AG; Reimer D; Schwentner L; Fuchs D; Wolf D; Fuith LC; Fiegl H; Doppler W; Concin N; Daxenbichler G; Marth C
Cancer Immunol Immunother; 2010 Dec; 59(12):1813-23. PubMed ID: 20717669
[TBL] [Abstract] [Full Text] [Related]
8. Curcumin suppresses constitutive activation of STAT-3 by up-regulating protein inhibitor of activated STAT-3 (PIAS-3) in ovarian and endometrial cancer cells.
Saydmohammed M; Joseph D; Syed V
J Cell Biochem; 2010 May; 110(2):447-56. PubMed ID: 20235152
[TBL] [Abstract] [Full Text] [Related]
9. In vivo survivors of transformed mouse ovarian surface epithelial cells display diverse phenotypes for gene expression and tumorigenicity.
Li XL; Zhang DQ; Wang D; Knight DS; Yin L; Bao J; Liu YY; Glass J; Mathis JM; Zhang QJ
Tumour Biol; 2008; 29(6):359-70. PubMed ID: 19052485
[TBL] [Abstract] [Full Text] [Related]
10. Expression of socs1 and SOCS3 genes is differentially regulated in breast cancer cells in response to proinflammatory cytokine and growth factor signals.
Evans MK; Yu CR; Lohani A; Mahdi RM; Liu X; Trzeciak AR; Egwuagu CE
Oncogene; 2007 Mar; 26(13):1941-8. PubMed ID: 17001312
[TBL] [Abstract] [Full Text] [Related]
11. [Correlations of CpG island methylator phenotype and OPCML gene methylation to carcinogenesis of hepatocellular carcinoma].
Liu WJ; Wang L; Wang JP; Li JQ; Zhang CQ; Zheng L; Yuan YF
Ai Zheng; 2006 Jun; 25(6):696-700. PubMed ID: 16764763
[TBL] [Abstract] [Full Text] [Related]
12. The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer.
Wolf D; Wolf AM; Rumpold H; Fiegl H; Zeimet AG; Muller-Holzner E; Deibl M; Gastl G; Gunsilius E; Marth C
Clin Cancer Res; 2005 Dec; 11(23):8326-31. PubMed ID: 16322292
[TBL] [Abstract] [Full Text] [Related]
13. [Acronycine revisited: development of benzo[b]acronycine antitumor agents].
Tillequin F; Koch M
Ann Pharm Fr; 2005 Jan; 63(1):35-43. PubMed ID: 15803099
[TBL] [Abstract] [Full Text] [Related]
14. Differential hypermethylation of SOCS genes in ovarian and breast carcinomas.
Sutherland KD; Lindeman GJ; Choong DY; Wittlin S; Brentzell L; Phillips W; Campbell IG; Visvader JE
Oncogene; 2004 Oct; 23(46):7726-33. PubMed ID: 15361843
[TBL] [Abstract] [Full Text] [Related]
15. [New antitumor agents in the acronycine series].
Tillequin F
Ann Pharm Fr; 2002 Jul; 60(4):246-52. PubMed ID: 12378151
[TBL] [Abstract] [Full Text] [Related]
16. [Reduced cisplatin-uptake by cisplatin-resistant human ovarian cancer cells].
Kikuchi Y; Iwano I; Miyauchi M
Gan To Kagaku Ryoho; 1988 Oct; 15(10):2895-8. PubMed ID: 3178239
[TBL] [Abstract] [Full Text] [Related]
17. [Effect of a newly developed platinum compound cis-1, 1-cyclobutane dicarboxylato-(2R)-2-methyl-1,4-butane diamine platinum (II), on human ovarian tumors transplanted into nude mice].
Sawada M; Ozaki M; Taniguchi H; Tateishi R; Mori Y; Mino K
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):637-41. PubMed ID: 3355185
[TBL] [Abstract] [Full Text] [Related]
